Cabot Wealth Management’s Chemed CHE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $12.4M | Sell |
26,608
-117
| -0.4% | -$49.2K | 1.26% | 32 |
|
|
2026
Q1 | $10.1M | Buy |
26,725
+1,521
| +6% | +$651K | 1.16% | 34 |
|
|
2025
Q4 | $10.8M | Buy |
25,204
+366
| +1% | +$159K | 1.19% | 32 |
|
|
2025
Q3 | $11.1M | Buy |
24,838
+681
| +3% | +$308K | 1.23% | 32 |
|
|
2025
Q2 | $11.8M | Buy |
24,157
+407
| +2% | +$232K | 1.4% | 27 |
|
|
2025
Q1 | $14.6M | Buy |
23,750
+329
| +1% | +$187K | 1.86% | 17 |
|
|
2024
Q4 | $12.4M | Buy |
23,421
+460
| +2% | +$259K | 1.58% | 24 |
|
|
2024
Q3 | $13.8M | Buy |
22,961
+202
| +0.9% | +$115K | 1.72% | 22 |
|
|
2024
Q2 | $12.3M | Sell |
22,759
-80
| -0.4% | -$45.8K | 1.62% | 23 |
|
|
2024
Q1 | $14.7M | Sell |
22,839
-15
| -0.1% | -$9.11K | 1.92% | 20 |
|
|
2023
Q4 | $13.4M | Sell |
22,854
-209
| -0.9% | -$117K | 1.86% | 21 |
|
|
2023
Q3 | $12M | Buy |
23,063
+311
| +1% | +$162K | 1.84% | 19 |
|
|
2023
Q2 | $12.3M | Buy |
22,752
+135
| +0.6% | +$73.8K | 1.84% | 21 |
|
|
2023
Q1 | $12.2M | Buy |
22,617
+69
| +0.3% | +$35.2K | 1.92% | 21 |
|
|
2022
Q4 | $11.5M | Sell |
22,548
-3,756
| -14% | -$1.83M | 1.94% | 18 |
|
|
2022
Q3 | $11.5M | Buy |
26,304
+1,249
| +5% | +$601K | 1.94% | 17 |
|
|
2022
Q2 | $11.8M | Buy |
25,055
+400
| +2% | +$195K | 1.87% | 21 |
|
|
2022
Q1 | $12.5M | Buy |
24,655
+611
| +3% | +$293K | 1.68% | 23 |
|
|
2021
Q4 | $12.7M | Buy |
24,044
+1,010
| +4% | +$485K | 1.61% | 23 |
|
|
2021
Q3 | $10.7M | Buy |
23,034
+212
| +0.9% | +$99.9K | 1.44% | 29 |
|
|
2021
Q2 | $10.8M | Buy |
22,822
+582
| +3% | +$279K | 1.45% | 28 |
|
|
2021
Q1 | $10.2M | Buy |
22,240
+2,787
| +14% | +$1.37M | 1.44% | 30 |
|
|
2020
Q4 | $10.4M | Buy |
19,453
+952
| +5% | +$468K | 1.59% | 24 |
|
|
2020
Q3 | $8.89M | Buy |
18,501
+69
| +0.4% | +$33.8K | 1.62% | 25 |
|
|
2020
Q2 | $8.31M | Buy |
18,432
+213
| +1% | +$95.1K | 1.66% | 24 |
|
|
2020
Q1 | $7.89M | Sell |
18,219
-352
| -2% | -$157K | 1.89% | 15 |
|
|
2019
Q4 | $8.16M | Buy |
18,571
+478
| +3% | +$201K | 1.58% | 24 |
|
|
2019
Q3 | $7.55M | Buy |
18,093
+39
| +0.2% | +$15.9K | 1.6% | 21 |
|
|
2019
Q2 | $6.51M | Buy |
18,054
+195
| +1% | +$65.2K | 1.37% | 27 |
|
|
2019
Q1 | $5.72M | Buy |
17,859
+125
| +0.7% | +$38.4K | 1.26% | 32 |
|
|
2018
Q4 | $5.02M | Sell |
17,734
-13
| -0.1% | -$3.92K | 1.23% | 31 |
|
|
2018
Q3 | $5.67M | Sell |
17,747
-410
| -2% | -$131K | 1.22% | 29 |
|
|
2018
Q2 | $5.84M | Sell |
18,157
-59
| -0.3% | -$18.5K | 1.3% | 28 |
|
|
2018
Q1 | $4.97M | Buy |
18,216
+160
| +0.9% | +$42.4K | 1.11% | 36 |
|
|
2017
Q4 | $4.39M | Sell |
18,056
-6
| -0% | -$1.36K | 0.95% | 41 |
|
|
2017
Q3 | $3.65M | Buy |
18,062
+715
| +4% | +$141K | 0.82% | 49 |
|
|
2017
Q2 | $3.55M | Buy |
17,347
+699
| +4% | +$139K | 0.82% | 46 |
|
|
2017
Q1 | $3.04M | Buy |
16,648
+388
| +2% | +$67.7K | 0.75% | 54 |
|
|
2016
Q4 | $2.61M | Buy |
+16,260
| New | +$2.39M | 0.71% | 51 |
|
Other funds holding CHE
EIP
Cabot Wealth Management's CHE Position: Q2 2026 in Review
Cabot Wealth Management reduced its Chemed (CHE) stake by 0.44% in Q2 2026, selling an estimated $49.2K and leaving 26,608 shares worth $12.4M. The position accounts for 1.26% of the portfolio, ranked #32.
Cabot Wealth Management first reported a position in CHE in Q4 2016 and has held it in 39 quarters since. The position peaked at $14.7M in Q1 2024. 530 funds tracked by Wall St. Rank hold CHE as of Q2 2026.
- Cabot Wealth Management held 26,608 shares of Chemed worth $12.4M as of Q2 2026.
- Cabot Wealth Management sold 117 Chemed shares in Q2 2026, an estimated $49.2K.
- Chemed made up 1.26% of Cabot Wealth Management's portfolio in Q2 2026, its #32 holding.
- Cabot Wealth Management first reported a position in Chemed in Q4 2016 and has held it in 39 quarters since.
- Cabot Wealth Management's Chemed position peaked at $14.7M in Q1 2024.
- 530 funds tracked by Wall St. Rank held Chemed as of Q2 2026.
Based on Cabot Wealth Management's 13F filing for Q2 2026, filed 31 Jul 2026.